Schwab Backs Out of $235M YieldPlus Class Action Lawsuit Settlement

Charles Schwab has announced that it is backing out of a proposed $235 million settlement agreement previously reached in a class action lawsuit over losses suffered by investors in the Schawb YieldPlus fund

The Schwab YieldPlus settlement agreement was announced earlier this year, but Schwab officials indicated last week that they are terminating the agreement, as they only recently found out that the settlement would only protect them from lawsuits by California investors, leaving other investors nationwide able to file individual claims.

Plaintiff attorneys say the coverage of the settlement was agreed upon early in the settlement process and will ask the U.S. District Court in San Francisco to hold the company in contempt of court for reneging on the deal, which was awaiting court approval.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The move by Schwab raised eyebrows among financial legal experts, who say that it is hard to believe Schwab only just found out that they were not fully covered from other lawsuits by the settlement agreement. It is rare for agreements to break down this late in the process, and how well protected the defendant will be from future lawsuits is usually one of the earliest subjects addressed in settlement talks. 

Schwab YieldPlus funds are ultra-short bond funds that were heavily promoted as conservative investment alternatives to money market funds or cash. Despite being advertised to generate income with minimal changes in share price, the fund lost more than 30% of its value between June 2007 and June 2008 due to heavy investments in risky subprime mortgage securities, which some experts indicate violated the prospectus.

The Schwab class action lawsuit represents about 250,000 investors who say they lost about $800 million when the YieldPlus fund tanked. The claim alleges that Schwab misled investors and failed to properly disclose the nature of the risks associated with certain securities held by the bond funds. Schwab still faces at least 194 individual stockbroker arbitration claims for up to $34 million. Those investors opted out of the class action lawsuit.

In October 2009, Schwab announced that it had received a “Wells notice” from the U.S. Securities and Exchange Commission (SEC) indicating that they plan to recommend that the company be brought up on civil charges. No charges have yet been filed.

1 Comments

  • TERRYFebruary 27, 2011 at 3:17 am

    THIS MY NOT JUST BE ONE FUND THAT WAS RUN WRONG. WE NEED TO LOOK INTO ALL THE FUNDS PROGRAMS THAT MY HAVE PROLBEN IN THAT TIME FRAME . WE DO NOT WANT TO OVER LOOK THIS . THIS COULD BEED DONE IN MORE AREAS THEN TWO AREAS... THANK YOU PLEASE READ AND COMMENT ON THIS PLEASE...

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

EU Launches Investigation Into Ozempic Vision Loss Problems
EU Launches Investigation Into Ozempic Vision Loss Problems (Posted 3 days ago)

Following nearly 20 reports of vision problems from Ozempic or Wegovy since a study was published in July 2024, Danish health officials are calling for an EU investigation into the safety of semaglutide-based drugs.